Cardiac sarcoidosis with extensive and heterogeneous left ventricular FDG uptake in absence of guidelines indication for an implantable defibrillator: Ventricular tachycardia precipitated by immunosuppressive therapy, should we have done differently?
Open Access
- 15 March 2024
- journal article
- research article
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 47 (9) , 1217-1223
Abstract
A 40‐year‐old man, newly diagnosed with cardiac sarcoidosis (CS) presented with symptomatic ventricular tachycardia three days after starting steroid‐based immunosuppressive therapy (IT). There was no clear guideline indication for implantable cardioverter‐defibrillator (ICD) before the initiation of IT. Shortly after ICD implantation and the initiation of anti‐arrhythmic drugs, recurring ventricular arrhythmias required titration of the anti‐arrhythmic drug therapy. One‐year follow‐up assessment showed no significant arrhythmias and complete PET scan FDG uptake suppression. This case, along with recent publications, suggests transient pro‐arrhythmic effects of steroids in patients with CS, which are not appropriately addressed in the current guidelines. We believe ICD implantation should be considered in clinically manifest CS before initiating IT, particularly in cases with heterogeneous and/or extensive FDG uptake on PET scans.Keywords
This publication has 20 references indexed in Scilit:
- New Perspective in Cardiac Sarcoidosis: The Potential Role of a Dedicated Clinic and the Importance of Collaboration Among Different SpecialtiesCanadian Journal of Cardiology, 2023
- 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac deathEuropean Heart Journal, 2022
- The role of electrophysiology study in risk stratification of cardiac sarcoidosis patients: Meta-analyses and systemic reviewInternational Journal of Cardiology, 2022
- 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summaryHeart Rhythm, 2018
- Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complete heart blockHeart Rhythm, 2015
- HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac SarcoidosisHeart Rhythm, 2014
- Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients With Suspected Cardiac SarcoidosisJACC, 2014
- Delayed enhancement on cardiac magnetic resonance imaging is a poor prognostic factor in patients with cardiac sarcoidosisJournal of Cardiology, 2012
- Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosisHeart Rhythm, 2007
- Ventricular tachyarrhythmia associated with cardiac sarcoidosis: Its mechanisms and outcomeClinical Cardiology, 2004